CH.6 Pharmacology Flashcards
Adrenergic (Sympathomimetic)
–Cardiopulmonary system
—increase in HR, BP, and RR
—Bronchodilation
–Eye
—Mydriasis (dilation)
–GI Tract
—Decreased motility
–Insulin secretion
—decreased
Sympathetic Nervous System
–When stimulated:
—relaxes the bronchial smooth muscle
—dilate the airways
—lowers airway resistance
– 3 Types of Receptors
—Alpha, beta 1 in heart, and beta 2 in the lungs
Airway Anatomy
-Thress layers of the airway
–Mucosa: innermost layer
—has goblet cells that produce sticky mucus to catch and debris
—ciliated cells
–Submucosa
—Bronchial glands
—smooth muscle
—capillary network
—elastic tissue
–Adventitia
—Support of airways
Bronchoconstriction
–reduction of the inner diameter of airway
–Bronchospasm: contraction of smooth muscle. Airway diameter is reduced, caused reduction in airflow
–Inflammation (Airway Edema): injury to mucous membranes causes dilation of the blood vessels, Swollen tissue reduces the diameter of the lumen of the airway.
–Secretions: impairment of the normal mucociliary clearance mechanism of the lungs. Secretions in the airway reduce the airway diameter.
Development of Beta Agonists: Catecholamines
–catechol nucleus and an amine side chain
–Not very Beta 2 specific
–Degraded by enzymes COMT and MAO, not given orally
–All sympathomimetic bronchodilators are either catecholamines or derivatives of catecholamines
Development of Beta Agonists: Resorcinols
–short duration of action
–resistant to breakdown by enzymes
–can be given orally
–derive from the catecholamines
Development of Beta Agonists: Saligenins
–most widely prescribed
–Most Beta 2 specific
–Rapid onset
—-derive from the catecholamines
Adrenergic Bronchodilators as Stereoisomers
–catecholamines and derivatives
– similar physical and chemical properties
–different physiological effects
–example: Levalbuterol
Nonsuperimposable Molecular Mirror images
–(R)-Isomer (right isomer) (levo), active on airway beta receptors producing bronchodilation
–(S)-Isomer (left isomer) (dextro), not active on adrenergic receptors
–Natural epinephrine from the adrenal gland occurs only in the R-isomer
–Racemic mixture have an S and R isomer
–example: Levalbuterol
Clinical Indications for Adrenergic Bronchodilators
–Relaxation of smooth airway muscle in the presence of reversible obstruction
–Can be short-acting or long-acting
–Asthma: acute, chronic, exercise-induced
–Bronchitis
–Emphysema
–Bronchiectasis
–Other obstructive airway disease
Indication for Short-Acting Agents
–Acute reversible airflow obstruction
–“rescue” agents or “ relievers”
–Albuterol
–Levalbuterol
–Metaproterenol
Indication for Long-Acting Agents
–maintenance bronchodilation, control of bronchospasm, and control of nocturnal symptoms
–“controllers”
–Salmeterol
–Formoterol
–Arformoterol
–Indacaterol
–Olodaterol
–Vilanterol
Bronchodilators’ Classification
–Ultrashort acting: duration less than 3 hours
—example: racemic epinephrine
–Short acting: duration of 4 to 6 hours
—examples: albuterol, levalbuterol, metaproterenol
–Long acting: duration of 12 to 24 hours
—examples: salmeterol, formoterol, arformoterol, indacaterol, olodaterol, vilanterol
Catecholamine
–Racemic Epinephrine: nebulized
–Control airway bleeding during endoscopy
–Reduce upper airway swelling: Postextubation stridor, Epiglottis, Croup, Bronchiolitis
–Allergic Reactions
–Decongestant
–Alpha-adrenergic vasoconstricting effect
Catecholamine: Racemic Epinephrine (Racemic Epi)
–Ultra-short acting
–Trade name: Asthmanefrin
–Mode of action: a and B receptors
–Method of administration: SVN 2.25%, 0.25-0.5 mL QID
–Onset: 3-5 mins
–Peak: 5-20 mins
–Duration: 0.5-2 hrs